Drug |
---|
show drug details
| PubChem ID: | 4184 |
---|
Structure: |  |
---|
Synonyms: | 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine | 2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine | 21535-47-7 | 21535-47-7 (mono-hydrochloride) | 24219-97-4 | AC-631 | AC1L1HLP | AKOS005216268 | Biomol-NT_000135 | BPBio1_000064 | BPBio1_000331 | BRD-A19661776-001-01-5 | BRD-A19661776-003-05-2 | BRN 0755346 | BSPBio_000058 | BSPBio_003511 | C18H20N2 | CCG-204829 | CHEBI:51137 | CHEMBL6437 | D08216 | DB06148 | Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl- | Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl- | DivK1c_000844 | EINECS 246-088-6 | HMS2089A04 | HSDB 7182 | IDI1_000844 | KBio1_000844 | KBio2_002301 | KBio2_004869 | KBio2_007437 | KBio3_003016 | KBioGR_001820 | KBioSS_002303 | L000736 | Lerivon | Lopac0_000744 | LS-61197 | MIANSERIN | Mianserin (INN) | Mianserin hydrochloride | Mianserin Monohydrochloride | Mianserin [INN:BAN] | Mianserina | Mianserina [INN-Spanish] | Mianserine | Mianserine [INN-French] | Mianserinum | Mianserinum [INN-Latin] | Mianseryna | Mianseryna [Polish] | NCGC00015656-04 | NCGC00015656-05 | NCGC00015656-06 | NCGC00015656-08 | NCGC00015656-09 | NCGC00015656-10 | NCGC00024926-03 | NCGC00024926-04 | NINDS_000844 | Norval | Oprea1_703627 | Org GB 94 | PDSP1_001532 | PDSP2_001516 | Prestwick0_000099 | Prestwick1_000099 | Prestwick2_000099 | Prestwick3_000099 | SPBio_000986 | SPBio_001997 | Spectrum2_001203 | Spectrum3_001836 | Spectrum4_001260 | Spectrum5_001772 | Spectrum_001810 | Tolvan | Tolvon | Tolvon (TN) |
|
---|
ATC-Codes: | |
---|
|
Target |
---|
show target details
| Uniprot ID: | ADA2A_HUMAN |
---|
Synonyms: | Alpha-2 adrenergic receptor subtype C10 | Alpha-2A adrenergic receptor | Alpha-2A adrenoceptor | Alpha-2A adrenoreceptor | Alpha-2AAR |
|
---|
EC-Numbers: | - |
---|
Organism: | Homo sapiens Human
|
---|
PDB IDs: | 1HLL 1HO9 1HOD 1HOF |
---|
Structure: |  1HOF |
---|
|